Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Simone Melega
Risk of Malignancies in Patients With Rheumatoid Arthritis Treated With Rituximab: Analyses of Global Postmarketing Safety Data and Long-Term Clinical Trial Data
Rheumatology and Therapy
Related publications
Incidence of Gastrointestinal Perforations in Patients With Rheumatoid Arthritis Treated With Tocilizumab From Clinical Trial, Postmarketing, and Real-World Data Sources
Rheumatology and Therapy
NK Cell Count as Predictor of Clinical Response in Patients With Rheumatoid Arthritis Treated With Rituximab
Biologics: Targets and Therapy
Oncology
Immunology
Gastroenterology
Pharmacology
Rheumatology
Allergy
Longterm Safety of Patients Receiving Rituximab in Rheumatoid Arthritis Clinical Trials
Journal of Rheumatology
Rheumatology
Allergy
Immunology
Effectiveness and Safety of Tocilizumab: Postmarketing Surveillance of 7901 Patients With Rheumatoid Arthritis in Japan
Journal of Rheumatology
Rheumatology
Allergy
Immunology
Long-Term Safety of Rituximab in Rheumatoid Arthritis: Analysis From the SUNSTONE Registry
Arthritis Care and Research
Rheumatology
OP0105 Long-Term Safety of Tocilizumab From Large Clinical Trial and Postmarketing Populations
Serological Markers Associated With Disease Activity in Patients With Rheumatoid Arthritis Treated With Rituximab
Journal of International Medical Research
Biochemistry
Medicine
Cell Biology
Safety of Rituximab in Rheumatoid Arthritis
Reumatismo
Rheumatology
Long-Term Safety and Effectiveness of Adalimumab for the Treatment of Japanese Patients With Rheumatoid Arthritis: 3-Year Results From a Postmarketing Surveillance of 552 Patients
Modern Rheumatology
Medicine
Rheumatology
